178 related articles for article (PubMed ID: 26633560)
1. Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.
Amatu A; Somaschini A; Cerea G; Bosotti R; Valtorta E; Buonandi P; Marrapese G; Veronese S; Luo D; Hornby Z; Multani P; Murphy D; Shoemaker R; Lauricella C; Giannetta L; Maiolani M; Vanzulli A; Ardini E; Galvani A; Isacchi A; Sartore-Bianchi A; Siena S
Br J Cancer; 2015 Dec; 113(12):1730-4. PubMed ID: 26633560
[TBL] [Abstract][Full Text] [Related]
2. Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.
Siravegna G; Sartore-Bianchi A; Mussolin B; Cassingena A; Amatu A; Novara L; Buscarino M; Corti G; Crisafulli G; Bartolini A; Tosi F; Erlander M; Di Nicolantonio F; Siena S; Bardelli A
Ann Oncol; 2017 Jun; 28(6):1302-1308. PubMed ID: 28368455
[TBL] [Abstract][Full Text] [Related]
3. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.
Lee J; Kim HC; Hong JY; Wang K; Kim SY; Jang J; Kim ST; Park JO; Lim HY; Kang WK; Park YS; Lee J; Lee WY; Park YA; Huh JW; Yun SH; Do IG; Kim SH; Balasubramanian S; Stephens PJ; Ross JS; Li GG; Hornby Z; Ali SM; Miller VA; Kim KM; Ou SH
Oncotarget; 2015 Sep; 6(27):24320-32. PubMed ID: 26172300
[TBL] [Abstract][Full Text] [Related]
4. Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.
Rolfo C; Ruiz R; Giovannetti E; Gil-Bazo I; Russo A; Passiglia F; Giallombardo M; Peeters M; Raez L
Expert Opin Investig Drugs; 2015; 24(11):1493-500. PubMed ID: 26457764
[TBL] [Abstract][Full Text] [Related]
5. Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
Drilon A; Siena S; Ou SI; Patel M; Ahn MJ; Lee J; Bauer TM; Farago AF; Wheler JJ; Liu SV; Doebele R; Giannetta L; Cerea G; Marrapese G; Schirru M; Amatu A; Bencardino K; Palmeri L; Sartore-Bianchi A; Vanzulli A; Cresta S; Damian S; Duca M; Ardini E; Li G; Christiansen J; Kowalski K; Johnson AD; Patel R; Luo D; Chow-Maneval E; Hornby Z; Multani PS; Shaw AT; De Braud FG
Cancer Discov; 2017 Apr; 7(4):400-409. PubMed ID: 28183697
[TBL] [Abstract][Full Text] [Related]
6. Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.
Ardini E; Menichincheri M; Banfi P; Bosotti R; De Ponti C; Pulci R; Ballinari D; Ciomei M; Texido G; Degrassi A; Avanzi N; Amboldi N; Saccardo MB; Casero D; Orsini P; Bandiera T; Mologni L; Anderson D; Wei G; Harris J; Vernier JM; Li G; Felder E; Donati D; Isacchi A; Pesenti E; Magnaghi P; Galvani A
Mol Cancer Ther; 2016 Apr; 15(4):628-39. PubMed ID: 26939704
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355
[TBL] [Abstract][Full Text] [Related]
8. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
Mac SM; Farnham PJ
Mol Carcinog; 2000 Feb; 27(2):84-96. PubMed ID: 10657901
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in
Smith KM; Fagan PC; Pomari E; Germano G; Frasson C; Walsh C; Silverman I; Bonvini P; Li G
Mol Cancer Ther; 2018 Feb; 17(2):455-463. PubMed ID: 29237803
[TBL] [Abstract][Full Text] [Related]
10. Localization of the Chinese hamster CAD gene reveals homology between human chromosome 2p and Chinese hamster 7q.
Bertoni L; Attolini C; Simi S; Giulotto E
Genomics; 1993 Jun; 16(3):779-81. PubMed ID: 8100805
[TBL] [Abstract][Full Text] [Related]
11. carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish.
Coxam B; Neyt C; Grassini DR; Le Guen L; Smith KA; Schulte-Merker S; Hogan BM
Dev Dyn; 2015 Jan; 244(1):1-9. PubMed ID: 25294789
[TBL] [Abstract][Full Text] [Related]
12. An unusual Alu repeat sequence within the CAD gene.
Davidson JN; Khattar NH; Chen KC
J Mol Evol; 1991 Feb; 32(2):162-6. PubMed ID: 1672552
[TBL] [Abstract][Full Text] [Related]
13. Organization and nucleotide sequence of the 3' end of the human CAD gene.
Davidson JN; Rao GN; Niswander L; Andreano C; Tamer C; Chen KC
DNA Cell Biol; 1990 Nov; 9(9):667-76. PubMed ID: 1979741
[TBL] [Abstract][Full Text] [Related]
14. Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.
Farago AF; Le LP; Zheng Z; Muzikansky A; Drilon A; Patel M; Bauer TM; Liu SV; Ou SH; Jackman D; Costa DB; Multani PS; Li GG; Hornby Z; Chow-Maneval E; Luo D; Lim JE; Iafrate AJ; Shaw AT
J Thorac Oncol; 2015 Dec; 10(12):1670-4. PubMed ID: 26565381
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 5' end of the growth-regulated Syrian hamster CAD gene.
Farnham PJ; Kollmar R
Cell Growth Differ; 1990 Apr; 1(4):179-89. PubMed ID: 1982061
[TBL] [Abstract][Full Text] [Related]
16. Entrectinib: First Global Approval.
Al-Salama ZT; Keam SJ
Drugs; 2019 Sep; 79(13):1477-1483. PubMed ID: 31372957
[TBL] [Abstract][Full Text] [Related]
17. The evolutionary history of the first three enzymes in pyrimidine biosynthesis.
Davidson JN; Chen KC; Jamison RS; Musmanno LA; Kern CB
Bioessays; 1993 Mar; 15(3):157-64. PubMed ID: 8098212
[TBL] [Abstract][Full Text] [Related]
18. Prioritizing the Catalytic Gatekeepers through Pan- Inhibitory Mechanism of Entrectinib against ALK, ROS1 and TRKA Tyrosine Kinases.
Salifu EY; Issahaku AR; Agoni C; Ibrahim MAA; Manimbulu N; Soliman MES
Cell Biochem Biophys; 2022 Mar; 80(1):11-21. PubMed ID: 35040089
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha.
Chen KF; Lai YY; Sun HS; Tsai SJ
Nucleic Acids Res; 2005; 33(16):5190-8. PubMed ID: 16155188
[TBL] [Abstract][Full Text] [Related]
20. Revision in sequence of CAD aspartate transcarbamylase domain of Drosophila.
Davidson JN; Kern CB
J Mol Biol; 1994 Oct; 243(2):364-6. PubMed ID: 7932764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
